Across TCGA pan-cancer cohorts, LINC01054 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of LINC01054’s most consistent transcriptional readouts.
The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where LINC01054 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01054 is over-expressed in tumor.
LIHC are the cancer types where LINC01054 tumor–normal differential expression is most reproducible.